Fingerprinting In Vivo and In Vitro Prion Strains

About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
September 01, 2020 - November 30, 2022
Grant ID
A2020039F
Mentor(s)
Carlo Condello, PhD, University of California, San Francisco
William DeGrado, PhD, University of California, San Francisco
Goals
Alzheimer’s Disease (AD) is associated with the misfolding of tau and Aβ proteins. AD shares important molecular characteristics with classical PrP prion diseases, including the induced misfolding of soluble proteins in an autocatalytic manner and the accumulation of insoluble amyloids. Different “conformational strains” of PrP give rise to different neurodegenerative diseases. Conformation sensitive dyes are used to rapidly screen and fingerprint these “conformational strains” of prion proteins.
Summary
My project goal is to fingerprint various prion strains in vivo as well as in vitro with molecules that light up when bound to prion fibrils. Prions are what make up the Aβ plaques and neurofibrillary tau tangles observed in the brains of Alzheimer’s and related neurodegenerative disease patients. Interestingly, how these prions assemble — prion conformation — gives rise to distinctive neurodegenerative disease. Herein, I develop technology to rapidly assess the degree of similarity of prion conformations. First aim describes the development of confocal imaging technology that rapidly assess prion conformations. Second aim fingerprints prion conformations from brain tissues and correlate its composition via proteome. Third aim develops a peptide that bind identified prion conformations. The outcome technology will provide rapid assessment of prion conformations at a macroscopic level, which are further correlated to brain region, disease type, and prion composition.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University